Skip to main content
Premium Trial:

Request an Annual Quote

Stanford Genomics Lab Installs BioTrove's Genotyping Platform

NEW YORK (GenomeWeb News) — Stanford University has purchased and installed a BioTrove genotyping platform to help it detect pathogens and conduct other projects, BioTrove said today.
 
The Stanford Genome Technology Lab will use the company’s OpenArray platform in SNP-genotyping and qPCR-based testing, and will try to develop other uses for the platform.
 
BioTrove said Stanford will use OpenArray plates in projects such as detecting Salmonella and other pathogens in food samples, and will explore developing “a method for solid-state synthesis.”
 
Financial terms of the agreement were not released.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.